NCT02167893View on ClinicalTrials.gov

"Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey Long-term Use Survey in Prostate Cancer Patients (96 Weeks)"

CompletedOBSERVATIONAL
Enrollment

11,288

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Prostate Cancer
Interventions
DRUG

Leuprorelin acetate

Leuprorelin acetate SR 11.25 mg injection kit

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT02167893 - "Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey Long-term Use Survey in Prostate Cancer Patients (96 Weeks)" | Biotech Hunter | Biotech Hunter